| Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia SG O'Brien, F Guilhot, RA Larson, I Gathmann, M Baccarani, F Cervantes, ... New England Journal of Medicine 348 (11), 994-1004, 2003 | 4661 | 2003 |
| Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia BJ Druker, F Guilhot, SG O'Brien, I Gathmann, H Kantarjian, N Gattermann, ... New England Journal of Medicine 355 (23), 2408-2417, 2006 | 4411 | 2006 |
| Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet H Döhner, EH Estey, S Amadori, FR Appelbaum, T Büchner, AK Burnett, ... Blood, The Journal of the American Society of Hematology 115 (3), 453-474, 2010 | 4343 | 2010 |
| Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic … BD Cheson, JM Bennett, KJ Kopecky, T Büchner, CL Willman, EH Estey, ... Journal of clinical oncology 21 (24), 4642-4649, 2003 | 3039 | 2003 |
| European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013 M Baccarani, MW Deininger, G Rosti, A Hochhaus, S Soverini, ... Blood, The Journal of the American Society of Hematology 122 (6), 872-884, 2013 | 2591 | 2013 |
| Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B LR Silverman, EP Demakos, BL Peterson, AB Kornblith, JC Holland, ... Journal of Clinical oncology 20 (10), 2429-2440, 2002 | 2234 | 2002 |
| Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia G Saglio, DW Kim, S Issaragrisil, P Le Coutre, G Etienne, C Lobo, ... New England Journal of Medicine 362 (24), 2251-2259, 2010 | 2110 | 2010 |
| Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid … JC Byrd, K Mrózek, RK Dodge, AJ Carroll, CG Edwards, DC Arthur, ... Blood, The Journal of the American Society of Hematology 100 (13), 4325-4336, 2002 | 2096 | 2002 |
| Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study: Presented in part at … CL Sawyers, A Hochhaus, E Feldman, JM Goldman, CB Miller, ... Blood, The Journal of the American Society of Hematology 99 (10), 3530-3539, 2002 | 1529 | 2002 |
| Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia KR Rai, BL Peterson, FR Appelbaum, J Kolitz, L Elias, L Shepherd, ... New England Journal of Medicine 343 (24), 1750-1757, 2000 | 1426 | 2000 |
| Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study MS Topp, N Gökbuget, AS Stein, G Zugmaier, S O'Brien, RC Bargou, ... The Lancet Oncology 16 (1), 57-66, 2015 | 1304 | 2015 |
| IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia … G Marcucci, K Maharry, YZ Wu, MD Radmacher, K Mrózek, D Margeson, ... Journal of clinical oncology 28 (14), 2348-2355, 2010 | 975 | 2010 |
| International randomized study of interferon vs STI571 (IRIS) 8-year follow up: sustained survival and low risk for progression or events in patients with newly diagnosed … M Deininger, SG O'Brien, F Guilhot, JM Goldman, A Hochhaus, ... Blood 114 (22), 1126, 2009 | 939 | 2009 |
| Adverse Prognostic Significance of KIT Mutations in Adult Acute Myeloid Leukemia With inv(16) and t(8;21): A Cancer and Leukemia Group B Study P Paschka, G Marcucci, AS Ruppert, K Mrózek, H Chen, RA Kittles, ... Journal of Clinical Oncology 24 (24), 3904-3911, 2006 | 854 | 2006 |
| Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer … SP Whitman, KJ Archer, L Feng, C Baldus, B Becknell, BD Carlson, ... Cancer research 61 (19), 7233-7239, 2001 | 824 | 2001 |
| A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811 RA Larson, RK Dodge, CP Burns, EJ Lee, RM Stone, P Schulman, ... | 805 | 1995 |
| Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series SM Smith, MM Le Beau, D Huo, T Karrison, RM Sobecks, J Anastasi, ... Blood 102 (1), 43-52, 2003 | 796 | 2003 |
| Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study RA Larson, BJ Druker, F Guilhot, SG O'Brien, GJ Riviere, T Krahnke, ... Blood, The Journal of the American Society of Hematology 111 (8), 4022-4028, 2008 | 760 | 2008 |
| Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia … JC Byrd, BL Peterson, VA Morrison, K Park, R Jacobson, E Hoke, ... Blood, The Journal of the American Society of Hematology 101 (1), 6-14, 2003 | 741 | 2003 |
| Further analysis of trials with azacitidine in patients with myelodysplastic syndrome: studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B LR Silverman, DR McKenzie, BL Peterson, JF Holland, JT Backstrom, ... Journal of Clinical oncology 24 (24), 3895-3903, 2006 | 718 | 2006 |
